Kausik Ray

Kausik Ray, a Professor of Public Health and Cardiologist at Imperial College London, discusses the 2025 ACC/AHA Acute Coronary Syndrome guidelines. He emphasizes the revolutionary shift from solely using statins to embracing combination therapies for lipid management. The conversation highlights the necessity of initiating these combinations—statins, ezetimibe, and PCSK9 inhibitors—simultaneously for high-risk patients. This approach aims to bridge the gap between clinical practice and evidence-based strategies, ultimately improving patient outcomes.